...
首页> 外文期刊>journal of pharmacy and pharmacology >In‐Vivo Pharmacological Studies of 2‐N‐Carboxamidinonormianserin, a Histamine and 5‐Hydroxytryptamine Antagonist Lacking Central Effects
【24h】

In‐Vivo Pharmacological Studies of 2‐N‐Carboxamidinonormianserin, a Histamine and 5‐Hydroxytryptamine Antagonist Lacking Central Effects

机译:In‐Vivo Pharmacological Studies of 2‐N‐Carboxamidinonormianserin, a Histamine and 5‐Hydroxytryptamine Antagonist Lacking Central Effects

获取原文
           

摘要

Abstract—The in‐vivo pharmacological properties have been examined of FCC5 (2‐N‐carboxamidino‐1, 2, 3, 4, 10, 14b‐hexahydrodibenzo (c.f.) pyrazino (1, 2‐α)azepine hydrochloride), a guanidino analogue of mianserin. FCC5 (30–100 μg kg−1, i.v.) caused long‐lasting (>1 h) attenuation of histamine‐ and 5‐hydroxytryptamine (5‐HT)‐induced bronchoconstriction in the anaesthetized guinea‐pig. FCC5 (≤lmg kg−1, i.v.) had no effect on submaximal bronchoconstrictor responses caused by i.v. acetylcholine or the thromboxane A2‐mimetic U46619 ((15S)‐hydroxy‐11α,9α‐(epoxymethano)prosta‐5Z,13E‐dienoic acid). The pressor effects of 5‐HT in anaesthetized and pithed rats were inhibited by FCC5 (0·3–1·0 mg kg−1, i.v.). Higher doses of FCC5 (3 mg kg−1, i.v.) reduced bradycardia and depressor responses to 5‐HT in anaesthetized rats. In anaesthetized cats and rats and also pithed rats, FCC5 (0·1–1·0 mg kg−1, i.v.) caused sympathomimetic effects as demonstrated by pressor responses and tachycardia. FCC5 (0·1–0·3 mg kg−1, i.v.) inhibited pressor responses to tyramine whereas those to noradrenaline and sympathetic nerve stimulation were potentiated. Oedema in the rat paw caused by intraplantar 5‐HT was inhibited by FCC5 (ID50 0·76 mg kg−1, i.p.; and 2·7 mg kg−1, p.o.). In decerebrate rats which had been spinalized at T6–8, fenfluramine‐induced facilitation of the flexor reflex of the anterior tibialis muscle was inhibited by mianserin (ID50 0·36 mg kg−1, i.p.) but not by FCC5 (≤3mg kg−1, i.p.). Head twitches in carbidopapretreated mice induced byl‐5‐hydroxytryptophan were inhibited by mianserin (ID50 0·11 mg kg−1, i.p.), but not by FCC5 (≤30 mg kg−1, i.p.). It is concluded that FCC5 possesses an

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号